Carlyle Secured Lending, Inc. (NASDAQ:CGBD) Q1 2024 Earnings Call Transcript

Carlyle Secured Lending, Inc. (NASDAQ:CGBD) Q1 2024 Earnings Call Transcript May 8, 2024

Carlyle Secured Lending, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Thank you for standing by, and welcome to the Carlyle Secured Lending First Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] As a reminder, today's program is being recorded. I'd like to introduce your host for today's program, Mr. Daniel Hahn, Shareholder Relations. Please go ahead, sir.

Daniel Hahn: Good morning, and welcome to Carlyle Secured Lending's first quarter 2024 earnings call. With me on the call this morning is Justin Plouffe, our Chief Executive Officer; and Tom Hennigan, our Chief Financial Officer. Last night, we filed our Form 10-K and issued a press release with the presentation of our results, which are available on the Investor Relations section of our website. Following our remarks today, we will hold a question-and-answer session for analysts and institutional investors. This call is being webcast, and a replay will be available on our website. Any forward-looking statements made today do not guarantee future performance, and any undue reliance should not be placed on them. These statements are based on current management expectations and involve inherent risks and uncertainties, including those identified in the Risk Factors section of our annual report on Form 10-K.

These risks and uncertainties could cause actual results to differ materially from those indicated. Carlyle Secured Lending assumes no obligation to update any forward-looking statements at any time. With that, I'll turn the call over to Justin.

Justin Plouffe: Thanks Dan. Good morning everyone and thank you all for joining. I'm Justin Plough, the CEO of the Carlyle BDCs and Deputy Chief Investment Officer of Carlyle's global credit platform. As you may know Aren LeeKong, who was previously CEO of the Carlyle BDCs, resigned to pursue new opportunities professionally. We have benefited from Aren’s industry expertise and leadership and thank him for his contributions. For those of you on the line that I have not spoken with before, I've been part of Carlyle's global credit team since 2007. Besides focusing more broadly on managing growth and credit strategies at Carlyle, I've also been a member of Carlyle's private credit investment committee since its inception. I look forward to taking on responsibility for the direct lending strategy and I'll be working very closely with existing leadership, most notably Tom Hennigan and Mike Hadley.

I've worked with Tom and Mike for over 12 years at Carlyle and I'm excited to continue our partnership in support of Carlyle Secured Lending and the broader Carlyle Direct Lending platform. And with that said, I'll focus my remarks today on three topics. First, I'll provide an overview of the first quarter 2024 financial results. Next, I'll touch on the current market environment and finally I'll conclude with a few comments on the quarter's investment activity and portfolio positioning. Starting off with earnings, we continue to see our financial performance benefit from the higher base rate environment. In the first quarter, we generated net investment income of $0.54 per share, which represents an annualized yield of nearly 13% based on our 331 NAF.

Our board of directors declared a total second quarter dividend of $0.47 per share, consisting of our base dividend of $0.40 plus the $0.07 supplemental. Our net asset value as of March 31st was $17.07 per share, up $0.08, or approximately 0.5% from the December 31st period, primarily as a result of our Q1 earnings outpacing our dividend. Turning now to the market environment, activity picked up in the first quarter of 2024 is the reopening of the syndicated loan market and tighter terms drove overall refinancing activity and rebalancing of private and public credit markets. LBO activity has picked up in 2024 and the broader M&A market is expected to become more active in the second half of the year, which we expect to result in an uptick in origination volume.

While we do not try to predict interest rates, our chief economist at Carlyle, Jason Thomas, is one of the few that saw significant rate cuts as improbable back in November of 2023. Now that the market consensus has caught up with him, we are pleased to report that despite interest rates stabilizing at higher than expected levels, Carlyle portfolio company data continues to show the real economy holding up well. Although we've seen pricing pressure increase, particularly in U.S. upper middle market, the core middle market where we operate continues to be comparatively less volatile. Originations in the first quarter were up over 30% year-over-year and our pipeline continues to expand with both regular way and differentiated deal flow. As a reminder, it has always been our goal to drive performance with a consistent approach to direct lending anchored in disciplined credit selection and conservative portfolio management.

We remain focused on our core middle market strategy and benefit from the differentiation provided by our access to the one Carlyle platform, while maintaining our ability to be dynamic in response to market changes. While increasing origination activity is a positive for our strategy, we are most focused on the overall credit performance of our existing portfolio. Non-accruals approved significantly in the first quarter, and as Tom will discuss in detail later, we completed the recapitalization of dermatology associates and successfully exited direct travel during the first quarter. Our portfolio remains highly diversified and is comprised of 174 investments in 131 companies across more than 25 industries. The median EBITDA across our core portfolio at the end of the quarter was $81 million.

The average exposure in any single portfolio company is less than 1% and 95% of our investments are in senior secured loans. As always, discipline and consistency drove performance in the first quarter and we expect these tenants to drive performance in future quarters. I will now hand the call over to our CFO, Tom Hennigan.

Tom Hennigan: Thank you Justin. Today I'll begin with a review of our first quarter earnings. Then I'll discuss portfolio performance and I'll conclude with detail on our balance sheet positioning. As Justin previewed, we had another strong quarter on the earnings front. Total investment income for the first quarter was $62 million, down slightly from prior quarter, as a decrease in prepayment and amendment fees was offset by an increase in OID acceleration, primarily from the successful exit of our investment in direct travel. Total expenses of $34 million were flat versus prior quarter. Of note, total interest expense was down modestly as base rates stabilized during the quarter and we had a lower average outstanding debt balance.

The result was net investment income for the first quarter of $28 million or $0.54 per share. And while that's down $0.02 per share compared to our all-time high from last quarter, it's still well above the prior year comparable period. Our board of directors declared the dividends for the second quarter of 2024 at a total level of $0.47 per share. That's comprised of the $0.40 base dividend plus a $0.07 supplemental, which is payable to shareholders of record as of the close of business on June 28th. This total dividend level reflects our new variable supplemental dividend policy of paying out at least 50% of excess earnings, which allows us to be flexible as the portfolio evolves and base rates fluctuate. Our base dividend coverage of 135% for the quarter remains above the BDC peer set average, and we've grown the base dividend by 25% since 2022.

At the same time, the total dividend level also represents an attractive yield of nearly 11% based on the recent share price. In terms of the forward look for earnings for the rest of 2024, we continue to see support at a $0.50 per share level based on the latest interest rate curves and our current conservative positioning on leverage. We've maintained a conservative disciplined approach that we believe will enable us to continue consistent dividend payouts in a variety of rate environments, including when rates normalize, to remain highly confident in our ability to comfortably meet and exceed our $0.40 base dividend and continue paying out supplemental dividends each quarter. On valuations, our total aggregate realized in an unrealized net gain was about $1 million for the quarter, supported by net positive movement in valuations.

This increase in valuations, combined with Q1 earnings exceeding the dividend, resulted in our NAV increasing from $16.99 to $17.07 per share. Turning to credit performance, we continue to see overall stability in credit quality across the portfolio. Similar to last quarter, there were no new non-accruals and no additions to our watch list, which are deals with risk ratings 4 or 5. The major headline in this quarter is that total non-accruals fell to only 0.2% of total investments at both fair value and amortized costs, the lowest level since our IPO in 2017. This was aided by the successful recapitalization of Dermatology Associates in February, which we previewed during last quarter's call. And we also completed the sale and exit of direct travel in Q1, another successful turnaround story which came off non-accrual back in mid-2022.

We continue to proactively manage the portfolio and are working with sponsors to ensure our borrowers have adequate liquidity, as we expect rates to remain higher for longer. While we're not immune to credit issues, transactions like Derm and Direct Travel highlight the capabilities of the broader Carlyle platform to maximize recoveries when challenges arise with portfolio companies. I'll finish by touching on our financing facilities and leverage. We continue to be well positioned on the right side of our balance sheet. Leverage is down quarter-over-quarter and we are intentionally running leverage conservatively at the lower end of our target range to maintain the flexibility to invest in attractive opportunities. Statutory leverage was about 1.13 times and net financial leverage ended the quarter modest to lower at 0.95 times.

This positioning allows us to remain opportunistic as the macroeconomic environment involves and deal activity lives to pick up at the second half 2024. With that, I'll turn the call back over to Justin.

Justin Plouffe: Thanks, Tom. I would like to finish by highlighting the consistency of our investment approach and to reiterate our overall investment strategy. We're primarily focused on making senior secured floating rate investments to U.S. companies backed by high quality sponsors primarily in the core middle market. Market demand for private credit remains high and we continue to focus on sourcing transactions with significant equity cushions, attractive leverage levels, strong documentation and attractive spreads relative to the market and historical originations through our disciplined, underwriting, prudent portfolio construction and conservative approach to risk management. With attractive new originations, a stable portfolio and reduced non-accruals, we've benefited from the continued execution of our strategy and remain committed to delivering a non-volatile cash flow stream to our investors through consistent income and solid credit performance.

I'd like to now hand the call over to the operator to take your question. Thank you.

See also

20 Wealthiest Countries in Asia and

20 Largest Publicly Traded Financial Companies in the US.

To continue reading the Q&A session, please click here.